Cargando…
EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer
BACKGROUND: Enhancer of zeste homolog 2 (EZH2), a member of the polycomb group proteins, has been shown to promote cancer progression and breast cancer stem cell (CSC) expansion. Breast CSCs are associated with resistance to radiation in inflammatory breast cancer (IBC), a rare but aggressive varian...
Autores principales: | Debeb, Bisrat G, Gong, Yun, Atkinson, Rachel L, Sneige, Nour, Huo, Lei, Gonzalez-Angulo, Ana Maria, Hung, Mien-Chie, Valero, Vicente, Ueno, Naoto T, Woodward, Wendy A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431485/ https://www.ncbi.nlm.nih.gov/pubmed/25051981 http://dx.doi.org/10.1186/s13046-014-0058-9 |
Ejemplares similares
-
Regulation and Role of EZH2 in Cancer
por: Yamaguchi, Hirohito, et al.
Publicado: (2014) -
NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer
por: Villodre, Emilly S., et al.
Publicado: (2020) -
Differential Effect of Phosphorylation-Defective Survivin on Radiation Response in Estrogen Receptor-Positive and -Negative Breast Cancer
por: Debeb, Bisrat G., et al.
Publicado: (2015) -
Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism
por: Debeb, Bisrat G., et al.
Publicado: (2016) -
Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer
por: Hu, Xiaoding, et al.
Publicado: (2021)